CRSP - Prediction: These 2 Stocks Could Double In the Next Year
2023-05-28 10:15:00 ET
The next 12 months could be dicey for the economy and the stock market, especially as the U.S. Federal Reserve recently predicted a recession could come by year-end. But even in this environment, some equities should perform just fine -- or even better.
Let's look at two examples: CRISPR Therapeutics (NASDAQ: CRSP) and Axsome Therapeutics (NASDAQ: AXSM) . These two biotechs have important catalysts that could lead to outsized gains in the near term and, even more importantly, over the long run.
CRISPR Therapeutics is a gene-editing-focused biotech with no product on the market. That could be about to change. The company has submitted regulatory applications for its leading candidate, exa-cel, in the U.S. and Europe. Exa-cel is a potential therapy for a pair of blood-related illnesses: transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD).
For further details see:
Prediction: These 2 Stocks Could Double In the Next Year